Jun Gui

1.5k total citations
23 papers, 784 citations indexed

About

Jun Gui is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jun Gui has authored 23 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jun Gui's work include Immune Cell Function and Interaction (6 papers), interferon and immune responses (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jun Gui is often cited by papers focused on Immune Cell Function and Interaction (6 papers), interferon and immune responses (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jun Gui collaborates with scholars based in China, United States and Malaysia. Jun Gui's co-authors include Sidong Xiong, Serge Y. Fuchs, Yue Yan, Kanstantsin V. Katlinski, Ruizhen Chen, Wei Xu, Constantinos Koumenis, J. Alan Diehl, Hallgeir Rui and Amy R. Peck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Jun Gui

22 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Gui China 15 394 281 240 84 83 23 784
Courtney B. Betts United States 15 176 0.4× 341 1.2× 290 1.2× 23 0.3× 132 1.6× 27 752
Shun He United States 15 667 1.7× 653 2.3× 590 2.5× 178 2.1× 129 1.6× 25 1.5k
Maya C. André Germany 17 441 1.1× 355 1.3× 275 1.1× 15 0.2× 54 0.7× 30 925
Jon E. Peterson United States 11 150 0.4× 308 1.1× 288 1.2× 44 0.5× 93 1.1× 22 692
Elisabeth Heere‐Ress Austria 16 231 0.6× 402 1.4× 732 3.0× 34 0.4× 80 1.0× 21 1.1k
Florent Carrette France 11 510 1.3× 259 0.9× 318 1.3× 22 0.3× 62 0.7× 16 853
Shan Huang China 15 208 0.5× 103 0.4× 390 1.6× 39 0.5× 140 1.7× 40 705
Mathieu Derouet Canada 15 451 1.1× 303 1.1× 609 2.5× 22 0.3× 204 2.5× 24 1.1k
Shi‐Wei Huang Taiwan 16 225 0.6× 174 0.6× 347 1.4× 16 0.2× 153 1.8× 35 732
Luca Rubino Italy 10 827 2.1× 455 1.6× 388 1.6× 21 0.3× 169 2.0× 21 1.3k

Countries citing papers authored by Jun Gui

Since Specialization
Citations

This map shows the geographic impact of Jun Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Gui more than expected).

Fields of papers citing papers by Jun Gui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Gui. The network helps show where Jun Gui may publish in the future.

Co-authorship network of co-authors of Jun Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Gui. A scholar is included among the top collaborators of Jun Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Gui. Jun Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hanjun, Wei Qiao, Cegui Hu, et al.. (2025). In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes. Cancer Immunology Research. 13(6). 939–956. 3 indexed citations
2.
Dalangood, Sumiya, Cegui Hu, Chenwei Yuan, et al.. (2025). Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis. Cell Reports. 44(11). 116526–116526.
3.
Qiao, Wen, Jingqi Chen, Cegui Hu, et al.. (2024). A Single‐Atom Manganese Nanozyme Mn‐N/C Promotes Anti‐Tumor Immune Response via Eliciting Type I Interferon Signaling. Advanced Science. 11(14). e2305979–e2305979. 48 indexed citations
4.
Liu, Yuanxin, et al.. (2024). Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders. Advanced Science. 11(41). e2400702–e2400702. 5 indexed citations
5.
Hu, Cegui, Wen Qiao, Xiang Li, et al.. (2024). Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells. Cell Metabolism. 36(3). 630–647.e8. 47 indexed citations
6.
Qiao, Wen, Cegui Hu, Jiayi Ma, et al.. (2023). Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity. Cancer Letters. 573. 216370–216370. 6 indexed citations
7.
Li, Jinyang, Fangxue Yan, Jun Gui, et al.. (2022). Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment. Cancer Immunology Research. 10(12). 1490–1505. 10 indexed citations
8.
Lu, Zhen, Jinyun Chen, Pengfei Yu, et al.. (2022). Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer. Nature Communications. 13(1). 6623–6623. 23 indexed citations
9.
Lv, Kaosheng, et al.. (2021). Depalmitoylation rewires FLT3-ITD signaling and exacerbates leukemia progression. Blood. 138(22). 2244–2255. 43 indexed citations
10.
Alicea-Torres, Kevin, Emilio Sanseviero, Jun Gui, et al.. (2021). Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. Nature Communications. 12(1). 1717–1717. 71 indexed citations
11.
Cho, Christina, Amy R. Peck, Yunguang Sun, et al.. (2020). Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis. Oncogene. 39(38). 6129–6137. 19 indexed citations
12.
Gui, Jun, Juriyati Jalil, Zakiah Jubri, & Yusof Kamisah. (2019). Parkia speciosa empty pod extract exerts anti-inflammatory properties by modulating NFκB and MAPK pathways in cardiomyocytes exposed to tumor necrosis factor-α. Cytotechnology. 71(1). 79–89. 23 indexed citations
13.
Gui, Jun, et al.. (2019). Modulation of NOX4 and MAPK Signaling Pathways by Parkia speciosa Empty Pods in H9c2 Cardiomyocytes Exposed to H2O2. Indian Journal of Pharmaceutical Sciences. 81(6). 10 indexed citations
14.
Lan, Jie, Rui Li, Limei Yin, et al.. (2018). Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 101(1). 74–87. 84 indexed citations
15.
Gui, Jun, Michael D. Gober, Xiaoping Yang, et al.. (2016). Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation. Journal of Investigative Dermatology. 136(10). 1990–2002. 28 indexed citations
16.
Gui, Jun, Ruizhen Chen, Wei Xu, & Sidong Xiong. (2015). Remission of CVB3‐induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up‐regulation. Journal of Cellular and Molecular Medicine. 19(4). 850–864. 22 indexed citations
17.
Yu, Qiujing, Bin Zhao, Jun Gui, et al.. (2015). Type I interferons mediate pancreatic toxicities of PERK inhibition. Proceedings of the National Academy of Sciences. 112(50). 15420–15425. 48 indexed citations
18.
Gui, Jun, Yue Yan, Ruizhen Chen, Wei Xu, & Sidong Xiong. (2012). A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-κB Signaling. PLoS ONE. 7(9). e46515–e46515. 58 indexed citations
19.
Yan, Yue, et al.. (2011). Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-Induced Myocarditis by Blunting Th1 Immune Responses. PLoS ONE. 6(3). e18186–e18186. 25 indexed citations
20.
Yan, Yue, Jun Gui, Wei Xu, & Sidong Xiong. (2010). Gene therapy with CCL2 (MCP-1) mutant protects CVB3-induced myocarditis by compromising Th1 polarization. Molecular Immunology. 48(4). 706–713. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Courtney B. Betts Breakdown of academic impact, for papers by Shun He Breakdown of academic impact, for papers by Maya C. André Breakdown of academic impact, for papers by Jon E. Peterson Breakdown of academic impact, for papers by Elisabeth Heere‐Ress Breakdown of academic impact, for papers by Florent Carrette Breakdown of academic impact, for papers by Shan Huang Breakdown of academic impact, for papers by Mathieu Derouet Breakdown of academic impact, for papers by Shi‐Wei Huang Breakdown of academic impact, for papers by Luca Rubino
Rankless by CCL
2026